These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18540372)

  • 21. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
    Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
    Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
    Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
    Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
    Godschalk PC; van Belkum A; van den Braak N; van Netten D; Ang CW; Jacobs BC; Gilbert M; Endtz HP
    J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
    Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Hye JB; Nachamkin I
    Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
    Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exchange of lipooligosaccharide synthesis genes creates potential Guillain-Barre syndrome-inducible strains of Campylobacter jejuni.
    Phongsisay V; Perera VN; Fry BN
    Infect Immun; 2006 Feb; 74(2):1368-72. PubMed ID: 16428786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Koga M; Yuki N
    Neurology; 2007 Oct; 69(17):1727-8; author reply 1728. PubMed ID: 17954791
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
    Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
    J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
    Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
    No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.